Poxvirus immunomodulatory strategies: current perspectives
about
Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a Naturally Infected PatientVaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signalingVaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family proteinStructure Function Studies of Vaccinia Virus Host Range Protein K1 Reveal a Novel Functional Surface for Ankyrin Repeat ProteinsA Unique Bivalent Binding and Inhibition Mechanism by the Yatapoxvirus Interleukin 18 Binding ProteinInhibition of Apoptosis and NF-κB Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to VirulencePoxviruses and the evolution of host range and virulenceIdentification of complement regulatory domains in vaccinia virus complement control protein.Surviving mousepox infection requires the complement systemDifferential transcription of fathead minnow immune-related genes following infection with frog virus 3, an emerging pathogen of ectothermic vertebrates.Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivoFowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits.Viral latency and its regulation: lessons from the gamma-herpesviruses.EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulenceEctromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.Novel immune-modulator identified by a rapid, functional screen of the parapoxvirus ovis (Orf virus) genome.N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.Dynamics of the major histocompatibility complex class I processing and presentation pathway in the course of malaria parasite development in human hepatocytes: implications for vaccine development.Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.Development of ST-246® for Treatment of Poxvirus Infections.Molecular characterization of the host defense activity of the barrier to autointegration factor against vaccinia virus.M135R is a novel cell surface virulence factor of myxoma virusImmune modulation in primary vaccinia virus zoonotic human infectionsGenetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs.Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbitsStructural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins.Smallpox antiviral drug development: satisfying the animal efficacy rule.Deciphering CD30 ligand biology and its role in humoral immunity.The potential role of fowlpox virus in rational vaccine design.Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virionsKinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.Ectromelia virus encodes a BTB/kelch protein, EVM150, that inhibits NF-κB signaling.Poxvirus exploitation of the ubiquitin-proteasome system.The molecular biology of frog virus 3 and other iridoviruses infecting cold-blooded vertebrates.Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding.Myxoma virus M064 is a novel member of the poxvirus C7L superfamily of host range factors that controls the kinetics of myxomatosis in European rabbits.The interplay between Araçatuba virus and host signaling pathways: role of PI3K/Akt in viral replication.Vaccinia virus dissemination requires p21-activated kinase 1.Myxoma virus: propagation, purification, quantification, and storage
P2860
Q21558605-569810BA-D228-44D6-8539-C008F7DB8C33Q24297063-C601DF2F-69AB-41A3-BE28-C2EE055E4C46Q24319056-1814ACCB-118B-443E-91C5-087FC70C9948Q27659058-3A0F40ED-2474-417F-B153-11FD051FEEC2Q27671728-C1B4A201-CA6F-4643-8F75-5A403672ADBAQ27676390-6B3B6F9D-FD70-4638-BB1E-AD260F48FC70Q28658130-480B94BA-D0AF-4F90-9721-6960D3733383Q30447940-413353FD-9D0A-4BAC-8971-8B783783DF8FQ33396210-7F24355E-39AF-4121-9758-11B056435726Q33713429-E02E1F7E-39BC-4A72-AA4F-9FCCBB1028E7Q33780691-20350A97-7B4B-4C37-A502-B8EF1599004BQ33863923-638FE84F-6B05-4719-AF73-2E7D14D902DEQ34039189-E7A66C2D-6E80-48B9-9364-6DB3F1883F7DQ34047542-84235B74-4DA8-4F6C-A892-CF8738F268ACQ34120177-BB7DACB5-BE48-4BC0-8F85-C48886B76292Q34127421-4EACC734-0F86-4DBB-822E-DBDF0CD6971AQ34742613-327C518D-78F6-404D-914C-52F2AD8935A4Q35005560-B1814BE6-7EBD-4E47-BC87-4A4DEFF04763Q35110264-2AA56DAD-EE86-470E-B735-0A49B811FF39Q35260385-E4E4843E-486C-45E0-8891-6843CD4B726AQ35531197-DF537FEF-5BDC-478E-8232-F692BC1837E1Q35634308-ABDFE226-5CBB-4231-BB7C-ADB9E8F63996Q35645804-993FF90A-5F26-43AD-8790-6B3B12B018F6Q35784301-2D21ACD4-1C8E-469C-BE08-7A15F6B3F948Q36315458-2DFB8389-D4B2-489F-8DAA-760A5843AD97Q36354883-94664DE3-C5DD-46C7-B99F-DA26457AFB8BQ36441506-AED0DA8D-6F4C-4072-A0B8-3AA8BE2AFEA7Q36505738-A096F217-691F-4DF8-80DB-397D2CA18D9BQ36600376-4CA028F2-1A5E-4303-8255-4886569B0268Q36839627-9DDA07E1-1327-44E3-8F27-F7B26A48387BQ37348541-8BEB4DC8-3AE1-4669-8E0C-9A9DEE126F97Q37713967-1039AD18-62DC-4259-B6D4-F97EE1DB07D6Q37945194-1E7CD4DF-1368-439D-9CFB-D2764C949A52Q37954258-8AD66F08-EEEF-421C-8E80-7CA980210EF1Q38671434-78302714-6AA7-4CBC-8A5B-8BB0C50BC17AQ39289960-E577428F-3377-4F67-BFA4-D039A57823D4Q39387769-10B0F70C-408B-48D8-BA6F-784D83CC46BBQ39511373-8020D94E-C64D-47D1-9D67-9EC3E8E43976Q39552891-90919141-4330-4AED-B66C-079B6CC48E65Q39707862-CBF08983-6E6A-4F89-B5C2-75E6F3BF4781
P2860
Poxvirus immunomodulatory strategies: current perspectives
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Poxvirus immunomodulatory strategies: current perspectives
@ast
Poxvirus immunomodulatory strategies: current perspectives
@en
type
label
Poxvirus immunomodulatory strategies: current perspectives
@ast
Poxvirus immunomodulatory strategies: current perspectives
@en
prefLabel
Poxvirus immunomodulatory strategies: current perspectives
@ast
Poxvirus immunomodulatory strategies: current perspectives
@en
P2860
P1433
P1476
Poxvirus immunomodulatory strategies: current perspectives
@en
P2093
J B Johnston
P2860
P304
P356
10.1128/JVI.77.11.6093-6100.2003
P407
P577
2003-06-01T00:00:00Z